Back to Journals » ClinicoEconomics and Outcomes Research » Volume 1

Breast cancer quality of life evaluation in Mexican Women at La Raza Hospital, Mexico City: A preliminary approach

Authors Gomez-Rico, Altagracia-Martinez M, Kravzov-Jinich J, Cardenas-Elizalde R, Hinojosa-Cruz JC, Rubio-Poo

Published 30 November 2008 Volume 2009:1 Pages 1—6


Review by Single-blind

Peer reviewer comments 3

Jacobo Alejandro Gómez-Rico1, Marina Altagracia-Martínez1, Jaime Kravzov-Jinich1, Rosario Cárdenas-Elizalde1, Juan Carlos Hinojosa-Cruz2, Consuelo Rubio-Poo3

1Departments of Biological Systems and Healthcare, Biological and Health Sciences Division (DCBS), Universidad Autónoma Metropolitana–Xochimilco (UAM-X), Xochimilco, Mexico; 2La Raza Hospital of the Mexican Social Security Institute (IMSS), Mexico City, Mexico; 3Universidad Nacional Autónoma de México (UNAM), Faculty of Professional Studies, Zaragoza (FES-Zaragoza), Mexico

Abstract: Breast cancer (BC) is the second leading cause of death among Mexican women over 40 years of age. This study aimed to identify and examine the effects of cancer stage and surgical treatment on the quality of life (QOL) of Mexican women with early stage breast cancer (ESBC) treated with either modified radical mastectomy (MRM) or breast conservative surgery (BCS), plus adjuvant chemotherapy. The QLQ-C30 and QLQ BR-23 questionnaires were used to assess QOL. Sociodemographic characteristics and clinical factors of 102 women with early BC were also evaluated; analysis of variance (ANOVA) was performed and a statistical significance of p < 0.05 was assumed. Most women were of reproductive age. Meaningful differences in QOL as a result of surgical treatment, in women receiving BCS compared with those receiving MRM, were limited to body image. We conclude that MRM and BCS are essentially equivalent choices in terms of QOL, with the exception of the impact on body image. In general, women who received BCS had a better perceived QOL.

Keywords: quality of life, breast cancer, Mexican women

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other articles by this author:

Potential prescription patterns and errors in elderly adult patients attending public primary health care centers in Mexico City

José Antonio Corona-Rojo, Marina Altagracia-Martínez, Jaime Kravzov-Jinich, et al

Clinical Interventions in Aging 2009, 4:343-350

Published Date: 12 August 2009

The costs of breast cancer in a Mexican public health institution

Jacobo Alejandro Gómez-Rico, Marina Altagracia-Martínez, Jaime Kravzov-Jinich, Rosario Cárdenas-Elizalde, Consuelo Rubio-Poo

Risk Management and Healthcare Policy 2008, 1:15-21

Published Date: 24 November 2008

Readers of this article also read:

Current perspectives in stem cell research for knee cartilage repair

Orth P, Rey-Rico A, Venkatesan JK, Madry H, Cucchiarini M

Stem Cells and Cloning: Advances and Applications 2014, 7:1-17

Published Date: 16 January 2014

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Biomarkers for osteoarthritis: investigation, identification, and prognosis

Zhai G, Aref Eshghi E

Current Biomarker Findings 2012, 2:19-28

Published Date: 29 June 2012

Topical diclofenac in the treatment of osteoarthritis of the knee

Niklas Schuelert, Fiona A Russell, Jason J McDougall

Orthopedic Research and Reviews 2011, 3:1-8

Published Date: 6 February 2011